Objective: Past research indicates that driving after cannabis use is relatively common. However, not all cannabis users are equally likely to drive after use; frequent cannabis users and frequent drivers are most at risk. It has been suggested that this is due to a perceived lack of impact of cannabis on driving ability.

Methods: The current study sought to better understand the motivation to drive after recent cannabis use. A survey was used to examine the self-reported impact of cannabis use on driving ability and, further, the amount of time cannabis users wait before driving after use. A total of 562 participants were recruited. Of these, 424 completed the survey and were included for analysis. Purposive sampling was used to screen for cannabis users who were over the age of 18 and residents of Connecticut.

Results: Cannabis use frequency was found to predict the self-reported impact of both recreational and medicinal cannabis on driving ability, such that more frequent cannabis users reported less impairment. Additionally, cannabis use frequency was predictive of wait time before driving, where more frequent users reported waiting less time before driving after cannabis use. A plurality of participants reported not waiting at all before driving after using cannabis. Notably, the self-reported impact of cannabis on driving ability was not associated with wait time before driving.

Conclusions: Cannabis users may not wait before driving even if they think it has a negative impact on their driving ability. Other factors that potentially impact driving after using cannabis warrant investigation.

Download full-text PDF

Source
http://dx.doi.org/10.1080/15389588.2023.2172679DOI Listing

Publication Analysis

Top Keywords

cannabis users
24
cannabis driving
20
driving ability
20
cannabis
18
driving cannabis
16
driving
14
wait time
12
time driving
12
impact cannabis
12
self-reported impact
12

Similar Publications

The association of medical cannabis use with quality of life in Illinois' opioid alternative pilot program.

J Epidemiol Popul Health

January 2025

Northwestern University Feinberg School of Medicine, Chicago, IL, United States; Center of Innovation for Complex Chronic Healthcare, Hines VA Hospital, Hines, IL, United States.

Background: In Illinois, the Opioid Alternative Pilot Program (OAPP) was launched to expand access to medical cannabis to use as a direct substitute for opioids. Although therapeutic benefits have been reported in reducing opioid use, there is an absence of literature that examines how medical cannabis use impacts an individual's quality of life (QoL). This study examines the association of medical cannabis use with QoL among the first enrollees in OAPP.

View Article and Find Full Text PDF

Determining the diagnostic cut-off on the Chinese version of severity of dependence scale for cannabis.

Front Psychiatry

January 2025

Department of Psychiatry, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.

Introduction: Cannabis use and misuse are surging among the Chinese community in East and Southeast Asia. A quick screening instrument that can effectively identify users with dependence for early intervention is in utmost need. This study examined the psychometric properties of the Chinese version of the Severity of Dependence Scale for cannabis (C-SDS-C) in screening for the DSM-5 defined Cannabis Use Disorder (CUD).

View Article and Find Full Text PDF

Evaluation of Cannabis Per Se Laws: A Semi-Mechanistic Pharmacometrics Model for Quantitative Characterization of THC and Metabolites in Oral Users.

J Clin Pharmacol

January 2025

Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, USA.

Recreational cannabis use has increased notably in the United States in the past decade, with a recent surge in oral consumption. This trend has raised concerns about driving under the influence. Current cannabis-impaired driving laws lack standardization, with some states implementing blood Δ9-tetrahydrocannabinol (THC) per se limits (1, 2, and 5 ng/mL).

View Article and Find Full Text PDF

Patterns of Maternal Single and Polysubstance Use in the US: A Latent Class Analysis.

J Stud Alcohol Drugs

January 2025

Department of Population Health Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States.

Objective: Substance use patterns vary considerably in the general population, yet little is known about patterns before and during pregnancy. The purpose of this study was to describe single substance and polysubstance use (PSU) before and during pregnancy among recent births in the United States (US) and compare exposure patterns.

Methods: We used data from the Pregnancy and Risk Assessment Monitoring System (PRAMS) postpartum survey for 2016-2018 to estimate the prevalence and identify patterns of substance use by participants one to three months before and during pregnancy.

View Article and Find Full Text PDF

Background: Cannabidiol (CBD) use has been increasing for its putative therapeutic potential for various health conditions. Research using a nationally representative sample is needed to examine characteristics of CBD users.

Methods: Data came from the adult sample (N=47,100) of the 2022 U.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!